Loading...
Risk Assessment generated by a regulatory process (RA)
  |  
BCH-RA-MY-266533-1   |   PDF   |   Print   |  
last updated: 07 Feb 2024
General Information
RISK ASSESSMENT REPORT OF THE GENETIC MODIFICATION ADVISORY COMMITTEE (GMAC) FOR AN APPLICATION FOR APPROVAL FOR RELEASE OF PRODUCTS OF MON87429 MAIZE FOR SUPPLY OR OFFER TO SUPPLY [JBK(S) 600-2/1/24]
EN
29 Sep 2022
Risk assessment details
  • MON-87429-9 - Dicamba, glufosinate, quizalofop and 2,4-dicholorophenoxyacetic acid tolerant maize with tissue-specific glyphosate tolerance
    | Monsanto | Resistance to herbicides (Glufosinate, Glyphosate), Tolerance to 2,4-dichlorophenoxyacetic acid, Tolerance to 3,6-dichloro-2-methoxybenzoic acid (dicamba), Tolerance to quizalofop
Please refer to the Risk Assessment Report.
EN
Methodology and points to consider
Please refer to the Risk Assessment Report.
EN
Please refer to the Risk Assessment Report.
EN
Please refer to the Risk Assessment Report.
EN
Please refer to the Risk Assessment Report.
EN
GMAC has conducted a thorough evaluation of the application for approval for importation for release [sale/placing on the market for direct use as food, feed and for processing (FFP)] of a product of a Living Modified Organism, dicamba, glufosinate, quizalofop and 2,4-dicholorophenoxyacetic acid tolerant MON87429 maize with tissue-specific glyphosate tolerance, and has determined that the release of this product does not endanger biological diversity or human, animal and plant health. GMAC recommends that the proposed application for release be APPROVED WITH TERMS AND CONDITIONS as listed in section IV - Proposed Terms and Conditions for Certificate of Approval..
EN
EN
EN
EN
Information sharing with other databases
Yes
Yes
Yes
Yes
Yes
Additional information
EN
Records referencing this document Show in search
Record type Field Record(s)
Country's Decision or any other Communication Risk assessment 1